Effects of Chaihu Jia Longgu Muli Decoction Combined with Dietary Intervention on Serum Antibody Profiles in Children with Tic Disorders
DOI:
https://doi.org/10.6911/WSRJ.202611_12(11).0001Keywords:
Tic disorders; Chaihu Jia Longgu Muli Decoction; dietary intervention; anti-streptolysin O; food-specific IgG.Abstract
This study investigated the effects of Chaihu Jia Longgu Muli Decoction combined with dietary intervention on serum anti-streptolysin O (ASO) and food-specific IgG antibodies in children with tic disorders (TD). Thirty children with TD were divided into two groups of 15 for combined intervention and traditional Chinese medicine (TCM) treatment, respectively, and 30 healthy children were selected as controls. Both treatment groups received Chaihu Jia Longgu Muli Decoction for 3 months, with additional dietary intervention in the combined group. The ASO positivity rate in children with TD was 66.7% (20/30), which differed significantly from that in healthy controls (P<0.05). After treatment, serum ASO levels decreased from 345.0 ± 25.6 to 239.1 ± 20.0 (t=3.36, P<0.05), while no significant difference was observed between the two treatment groups (P>0.05). Although food-specific IgG antibody distributions were comparable before treatment (P=0.418), a significant between-group difference was observed after treatment (χ²=6.930, P=0.031). In the combined group, the total number of positive antibodies decreased by 41.5%, from 41 to 24, while the number of 3+ antibodies decreased from 11 to 1. These results suggest that treatment was associated with a reduction in ASO levels, while additional dietary intervention was associated with changes in food-specific IgG antibody profiles. However, the clinical significance of these antibody changes remains unclear and warrants further investigation.
Downloads
References
[1] Desai, I., Kumar, N., & Goyal, V. (2023). An update on the diagnosis and management of tic disorders. Annals of Indian Academy of Neurology, 26(6), 858–870. https://doi.org/10.4103/aian.aian_724_23.
[2] Szejko, N., Robinson, S., Hartmann, A., Ganos, C., Debes, N. M., Skov, L., Haas, M., Rizzo, R., Stern, J., Münchau, A., Czernecki, V., Dietrich, A., Murphy, T., Martino, D., Tarnok, Z., Hedderly, T., Müller-Vahl, K. R., & Cath, D. C. (2022). European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part I: assessment. European Child & Adolescent Psychiatry, 31(3), 383–402. https://doi.org/10.1007/s00787-021-01898-0
[3] Lin, W. D., Tsai, F. J., & Chou, I. C. (2022). Current understanding of the genetics of Tourette syndrome. Biomedical Journal, 45(2), 271–279. https://doi.org/10.1016/j.bj.2021.08.004
[4] Jafari, F., Abbasi, P., Rahmati, M., Hodhodi, T., & Kazeminia, M. (2022). Systematic review and meta-analysis of Tourette syndrome prevalence; 1986 to 2022. Pediatric Neurology, 137, 6–16. https://doi.org/10.1016/j.pediatrneurol.2022.08.010
[5] Kutuk, M. O., Tufan, A. E., Kilicaslan, F., Gokcen, C., Aksu, G. G., Yektas, C., Kandemir, H., Celik, F., Mutluer, T., Buber, A., Karadag, M., Coban, N., Coskun, S., Hangul, Z., Altintas, E., Acikbas, U., Giray, A., Aka, Y., Basturk, B., & Kutuk, O. (2024). Cytokine expression profiles in children and adolescents with tic disorders. Scientific Reports, 14, 15101. https://doi.org/10.1038/s41598-024-62121-z
[6] Geng, J., Liu, C., Xu, J., Wang, X., & Li, X. (2023). Potential relationship between Tourette syndrome and gut microbiome. Jornal de Pediatria, 99(1), 11–16. https://doi.org/10.1016/j.jped.2022.06.002
[7] Liang, Y., Wan, L., Wang, G., Yan, H., Zhang, J., Liu, X., Zhang, Z., Zhu, G., & Yang, G. (2025). Clinical study of Limosilactobacillus reuteri for the treatment of children with chronic tic disorders/Tourette syndrome: A mid-term efficacy evaluation. Neurology and Therapy, 14(1), 279–290. https://doi.org/10.1007/s40120-024-00664-8
[8] Kang, X., Cheng, E., Guo, P., Xi, L., Xiang, C., Xu, S., Yang, Y., Zhang, J., Long, H., & Zhang, Y. (2025). Jing An decoction alleviates neuroinflammation in Tourette syndrome by regulating butyrate-mediated microbiota-gut-brain axis. Phytomedicine, 145, 157009. https://doi.org/10.1016/j.phymed.2025.157009
[9] Santos, A. F., Riggioni, C., Agache, I., Akdis, C. A., Akdis, M., Alvarez-Perea, A., Alvaro-Lozano, M., Ballmer-Weber, B., Barni, S., Beyer, K., Bindslev-Jensen, C., Brough, H. A., Buyuktiryaki, B., Chu, D., Del Giacco, S., Dunn-Galvin, A., Eberlein, B., Ebisawa, M., Eigenmann, P., Eiwegger, T., Feeney, M., Fernandez-Rivas, M., Fisher, H. R., Giovannini, M., Gray, C., Hoffmann-Sommergruber, K., Halken, S., Hourihane, J. O., Jones, C. J., Jutel, M., Knol, E., Konstantinou, G. N., Lack, G., Lau, S., Marques Mejias, A., Marchisotto, M. J., Meyer, R., Mortz, C. G., Moya, B., Muraro, A., Nilsson, C., Lopes de Oliveira, L. C., O'Mahony, L., Papadopoulos, N. G., Perrett, K., Peters, R. L., Podesta, M., Poulsen, L. K., Roberts, G., Sampson, H. A., Schwarze, J., Smith, P., Tham, E. H., Untersmayr, E., Van Ree, R., Venter, C., Vickery, B. P., Vlieg-Boerstra, B., Werfel, T., Worm, M., Du Toit, G., & Skypala, I. (2023). EAACI guidelines on the diagnosis of IgE-mediated food allergy. Allergy, 78(12), 3057–3076. https://doi.org/10.1111/all.15902
[10] Gagliano, A., Carta, A., Tanca, M. G., & Sotgiu, S. (2023). Pediatric acute-onset neuropsychiatric syndrome: Current perspectives. Neuropsychiatric Disease and Treatment, 19, 1221–1250. https://doi.org/10.2147/NDT.S362202
[11] Vreeland, A., Calaprice, D., Or-Geva, N., Frye, R. E., Agalliu, D., Lachman, H. M., Pittenger, C., Pallanti, S., Williams, K., Ma, M., Mellins, E., Gagliano, A., & Frankovich, J. (2023). Postinfectious inflammation, autoimmunity, and obsessive-compulsive disorder: Sydenham chorea, pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection, and pediatric acute-onset neuropsychiatric disorder. Developmental Neuroscience, 45(6), 361–374. https://doi.org/10.1159/000531475
[12] American Academy of Pediatrics, Board of Directors. (2025). Pediatric acute-onset neuropsychiatric syndrome (PANS): Clinical report. Pediatrics, 155(3), e2024070334. https://doi.org/10.1542/peds.2024-070334
[13] Zhao, Y., Xu, D., Wang, J., Zhou, D., Liu, A., Sun, Y., Yuan, Y., Li, J., & Guo, W. (2023). The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: Integrated meta-analysis and network pharmacology analysis. Frontiers in Pharmacology, 14, 1257617. https://doi.org/10.3389/fphar.2023.1257617
[14] Tang, Y. J., & Liu, X. M. (2024). Research progress on dietary nutrition and intestinal flora in children with tic disorder. Chinese Journal of Child Health Care, 32(11), 1232–1235. https://doi.org/10.11852/zgetbjzz2023-1384
[15] Canadian Society of Allergy and Clinical Immunology. (2025). Allergy & clinical immunology: Eight tests and treatments to question. Choosing Wisely Canada. https://choosingwiselycanada.org/recommendation/allergy-clinical-immunology/
[16] American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 World Scientific Research Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




